ArticleBrain : a journal of neurology2026
Recessive variants in mitochondrial complex I nuclear subunits are an underrated cause of optic atrophy.
Article in Brain : a journal of neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Article
- Novel NDUFV1 variant in progressive cavitating leukodystrophy with microcephaly: a case report.BMC pediatrics · 2026Article
- Expanding the Phenotypic Spectrum of NDUFS6-Related Disease: From Neonatal Mitochondrial Encephalopathy to Childhood-Onset Axonal Neuropathy.International journal of molecular sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
47 authors.
Funding
Abstract
Our understanding of the genetic landscape of inherited optic neuropathies (ION) has grown significantly over the past decades, and it is now known to involve many genes found in both the nuclear and mitochondrial genomes, exhibiting all possible inheritance patterns. Furthermore, pathogenic variants in nuclear genes encoding mitochondrial respiratory complex I (CI) subunits have been identified in some cases of ION, in addition to the more common severe presentation of CI deficiencies, which usually have an early onset. We conducted next-generation sequencing screening of CI genes to identify potential causative variants in patients with optic atrophy, and performed comprehensive clinical assessments, including neuroimaging (MRI) and neurological evaluations. Detailed molecular structure modelling was performed to better evaluate the damaging effects of both novel and previously reported variants in the relevant CI subunits. We identified candidate causative variants in 31 patients from 23 unrelated families, with biallelic or hemizygous variants characterized in 11 nuclear CI-related genes encoding polypeptides involved in CI structure, including three core subunits (NDUFS7, NDUFV1, NDUFV2), four accessory subunits (NDUFA1, NDUFA10, NDUFA12, NDUFB11) and four assembly factors (NDUFAF2, NDUFAF3, NDUFAF4, NDUFAF8). Notably, defects in core CI subunits in this cohort led to isolated optic atrophy, while defects in accessory CI subunits and assembly factors resulted in a spectrum of phenotypes, from isolated to syndromic optic atrophy. In 12 cases, the subacute onset of vision loss enabled us to associate or confirm novel genes (NDUFS7, NDUFV1, NDUFAF2, NDUFAF4, NDUFAF8) with the autosomal recessive Leber hereditary optic neuropathy (arLHON) phenotype. Moreover, in the NDUFS7 subunit, partial spatial segregation was observed for missense variants associated with either Leigh syndrome or isolated optic atrophy, suggesting possible disease-specific molecular defects. Our case series broadens the genetic spectrum of ION, emphasizing the crucial role of nuclear CI genes in pathogenesis. The arLHON phenotype, reportedly associated with an insidious onset of optic atrophy, is linked to numerous nuclear CI genes, and in some cases, the same variant may underlie both phenotypes. Overall, we highlight the possibly underestimated prevalence of CI nuclear subunits in the molecular diagnosis of ION, prompting the inclusion of all CI-related genes in the standard diagnostic screening.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.